Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
21 studies found for:    " July 11, 2007":" August 10, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus
Conditions: Hepatitis C Virus;   Hiv Infections
Intervention: Drug: bavituximab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-21) Next Page   
Study has passed its completion date and status has not been verified in more than two years.